Tenapanor
Records for this ingredient, by country (identity only).
ATC A06AX08 · 4 markets · 10 records
US 4 records · 4 shown of 4
- 30 mgtabletXPHOZAH 30 mg
- 20 mgtabletXPHOZAH 30 mg
- 10 mgtabletXPHOZAH 30 mg
- 53.2 mgtabletIBSRELA
JP 4 records · 4 shown of 4
- 30 mgtabletフォゼベル錠30mg
- 20 mgtabletフォゼベル錠30mg
- 10 mgtabletフォゼベル錠30mg
- 5 mgtabletフォゼベル錠30mg
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名IBSRELA ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | HK | JP |
|---|---|---|---|
| 30 mg tablet | XPHOZAH 30 mg | フォゼベル錠30mg | |
| 20 mg tablet | XPHOZAH 30 mg | フォゼベル錠30mg | |
| 10 mg tablet | XPHOZAH 30 mg | フォゼベル錠30mg | |
| 53.2 mg tablet | IBSRELA | ||
| 5 mg tablet | フォゼベル錠30mg | ||
unknown | IBSRELA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.